Application of fuzzy logic for diabetes monitoring / Ag Mohd Fathi Fawwaz Ag Mohd Tahir by Ag Mohd Fathi Fawwaz, Ag Mohd Tahir
iii 
 
ABSTRACT 
 
 Diabetes is one of the most dangerous disease in the world; by 2025, at least 300 
million people will have diabetes. The main objective of this research project is to apply 
fuzzy logic system for the purpose of monitoring diabetic patient’s blood glucose level. 
The fuzzy logic system for monitoring blood glucose level was developed by using 
Matlab’s fuzzy inference system editor. For this project, two input variables and one 
output variables with 12 linguistic rules were implemented to develop the fuzzy logic for 
diabetic monitoring. The data obtained from the system is then compared with the real 
condition. Based on the comparison done for this project, fuzzy logic system shows a 
promising potential to be used as a control strategy in monitoring patient’s blood glucose 
level; the percent accuracy for the fuzzy logic system is 83%. In the future, the system 
can be integrated with blood glucose monitoring device and insulin pump; the 
combination is called artificial pancreas. With the advent of machine learning, the system 
can be further improved for benefits of diabetic patient.  
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ABSTRAK 
 
 Penyakit diabetes adalah salah satu penyakit yang paling bahaya di seantero 
dunia; dijangka sekurang-kurangnya 300 juta orang akan menghadapi penyakit tersebut 
pada tahun 2025. Tujuan utama projek penyelidikan ini dijalankan adalah untuk 
menggunakan system logik kabur (fuzzy logic) untuk mengawasi kadar gula yang berada 
di dalam darah penyakit diabetes. Fuzzy Inference System editor yang terdapat di dalam 
perisian Matlab telah digunakan untuk mencipta system logic kabur khusus untuk 
mengawasi kadar gula di dalam darah penyakit. Untuk projek ini, 2 masukan berubah-
ubah dan 1 keluaran berubah-ubah disertai dengan 12 peraturan linguistik telah digunakan 
untuk mencipta system logik kabur untuk mengawasi kadar gula di dalam darah penyakit. 
Data yang diperoleh dari sistem tersebut akan dibandingkan dengan keadaan sebenar. 
Berdasarkan kajian yang dibuat dalam projek ini, sistem logik kabur ini memperoleh 83% 
ketepatan. Pada masa hadapan, sistem yang dicipta dari matlab ini dapat disatukan dengan 
pam insulin dan alat pengawal gula di dalam darah; gabungan ini dipanggil pankreas 
buatan. Dengan kemunculannya teknik pembelajaran mesin, sistem ini dapat 
meningkatkan prestasinya dan menolong penyakit diabetes mengawal dan mengawasi 
kandungan gula di dalam darah mereka. 
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CHAPTER 1: INTRODUCTION 
 
1.1 Overview 
  
Diabetes is one of the most dangerous diseases in the world. According to Horton 
(2009), approximately 333 million people will have diabetes by 2025. Based on statistic 
produced by Malaysia’s Ministry of Health, 3.6 million Malaysian has diabetes 
(Bernama, 2017). A person is diagnosed with diabetes when his/her blood glucose level 
is more than 126 mg/dl if he/she is fasting; when tested 2 hours after meal, a person is 
considered diabetic when their blood glucose level is more than 200 mg/dl. Diabetes 
occurred due to body pancreas either failed to produce insulin or it only produce little 
amount of it; another reason is mainly due to insulin resistance where patient’s body does 
not respond appropriately to insulin. 
 Diabetes can be categorized into two types; the first type is called Type 1 diabetes. 
This type of diabetes is mainly hereditary and it occurs due to insulin producing cell called 
Beta cell in pancreas being destroyed by the immune system; thus, patients with Type 1 
diabetes need to constantly monitor and maintain their blood glucose at optimal level. 
The second type is called gestational diabetes and this type of diabetes occurs to pregnant 
patients who are over 25 years old and their body mass index (BMI) is above their normal 
level; according World Health Organization, this type of diabetes occurred in 4% of all 
pregnancy. The most common diabetes is Type 2 diabetes; out of 333 million that will 
have diabetes by 2025, 90-95% of the diabetic patients will have type 2 diabetes. This 
type of diabetes mainly occurs due to poor lifestyle choices such as diet rich in sugar and 
lack of exercise. While most type 2 diabetes patients are overweight or obese, it can also 
occur to non-obese patients (Heianza et al., 2014,). 
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1.2 Problem Statement 
 
Patients with diabetes required constant blood glucose monitoring. Traditional 
method, where blood glucose is monitored manually, can be a burden to patients; 
monitoring blood glucose level before meal, after meal, while patient is fasting, and 
before bedtime are required to prevent hypoglycemia or hyperglycemia. There are many 
control strategies used in diabetes monitoring, but the technique used is either never been 
described by the researcher because it is a trade secret or requires deep understanding of 
mathematical concept. 
1.3 Report Organization 
  
 This report consists of 5 chapters and they are: introduction, literature review, 
methodology, result and discussion, and conclusion. The introduction part will briefly 
explain the overall state of the disease and discuss the problem statement and overall 
objective of this project. The literature review chapter discusses the cause and effect of 
diabetes and briefly explains the concept of fuzzy logic and its application in diabetes and 
other medical field; then, this chapter discuss and analyse other control strategy used by 
experts in the field. The methodology section explains the step taken to develop and 
modify the system. The result and discussion chapter will discuss about the data obtained 
from the system by comparing it to real condition. The conclusion chapter will summarize 
all the findings of the report. 
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1.4 Objective 
  
The aim of this study is to develop a fuzzy logic model in order to monitor the 
blood glucose level of diabetic patient. While research in the application of fuzzy logic 
into diabetes monitoring has been done, the technique used is either never been described 
by the researcher or requires deep understanding of mathematical concept; thus, the 
objectives of this project are: 
1. To use Matlab’s fuzzy inference system (FIS) editor to simulate the application 
of fuzzy logic into diabetic monitoring. 
2. Analyse the accuracy of the fuzzy logic system with real life condition. 
3. To understand the benefits of artificial pancreas, a system that integrate control 
strategy system such as the fuzzy logic system with insulin pump and diabetic 
monitoring devices. 
4. To briefly mentions the integration of artificial pancreas with machine learning 
algorithm. 
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CHAPTER 2: LITERATURE REVIEW 
 
2.1 Cause of Diabetes 
 
 There are differences in the cause of incurring type 1 and type 2 diabetes and thus 
thorough understanding of both types of diabetes are needed in order to integrate it with 
the fuzzy logic model. 
2.1.1 Type 1 Diabetes 
 
 Type 1 diabetes occurs mainly due to genetic disorder; patients with type 1 
diabetes cannot produce insulin because beta cell, a type of cell that is responsible in the 
production of insulin, is destroyed by the immune system. 
2.1.2 Type 2 Diabetes 
 
 Type 2 diabetes is the most common diabetes incurred by diabetic patients and it 
mainly occurs due to poor lifestyle choices such as unhealthy diet and infrequent exercise. 
Many diabetic patients have body mass index (BMI) that is 25 and above and thus can be 
categorized as overweight or obese, yet the correlation between obesity and incurring 
diabetes is slightly blurred. It can be deduced that obesity occurs mainly due to poor 
lifestyle choices, but not all overweight or obese subject has diabetes. Even so, Heianza 
et al. (2014) argued that obese subject has higher chances of incurring diabetes; for 
instance, it was found that metabolically healthy but obese individuals “had a 
significantly increased HR [hazard ratio] for diabetes” as compared to metabolically 
healthy and normal BMI individuals (p. 2422). The hazard ratio was calculated using Cox 
regression analysis. Furthermore, individuals that has hypertension, 
hypertriglyceridemia, and low HDL cholesterol concentration will have higher chances 
of incurring diabetes even though the BMI indicates that the person is not obese. 
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 Type 2 diabetes is a progressive disease and thus has devastating deteriorative 
affect; initially, it can be combatted by having a healthy diet followed by regular exercise. 
But Khan, St. Peter, Breen, Hartley, and Vessey (2010) warns that “intervention [in 
diabetic patients’ activities] must be balanced with potential risk” (p. 46). As the disease 
progress, the diet and the exercise must be altered (Khan et al., 2010).   
2.2 Consequence of Diabetes 
 
 Diabetic patients need to constantly monitor their blood glucose level to avoid 
diabetic complications due to hyperglycemia. According to Cade (2008), the aftereffect 
of hyperglycemia can be categorised into two vascular complication; some of the effect 
related to microvascular complications are diabetic neuropathy, nephropathy, and 
retinopathy; the other is related to macrovascular complications such as coronary artery 
disease, peripheral disease, and stroke.  
 In addition to hyperglycemia, diabetic patients may also experience 
hypoglycemia. Kavakiotis et al. (2017) mentioned that hypoglycemia occurs “mainly due 
to anti-diabetic treatment and [it] has a great impact among DM [Diabetes mellitus] 
patients” (p. 109). The insulin-producing drugs consumed in order to increase the level 
of insulin in patient’s body system may sometime result in dramatic decrease in blood 
glucose level that is below the accepted level. According to Feldman-Billard, Massin, 
Meas, Guillausseau, and Heron, hypoglycemia may cause the increase of blood pressure, 
which increase the chance of diabetic patient to incur cardiovascular related disease. 
2.3 Glycemic Control 
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Table 2.1: Relationship between HbA1c and blood glucose level 
(AmericanDiabetesAssociation) 
A1C 
% 
(mmol/mol) 
Mean 
Plasma 
Glucose 
(mg/dl) 
Mean 
Fasting 
Glucose 
(mg/dl) 
Mean 
Premeal 
Glucose 
(mg/dl) 
Mean 
Postmeal 
Glucose 
(mg/dl) 
Mean 
Bedtime 
Glucose 
(mg/dl) 
6 (42) 126 (100-
152) 
    
5.5-6.49 
(37-47) 
 122 (117-
127) 
118 (115-
121) 
144 (139-
148) 
136 (131-
141) 
6.5-6.99 
(47-53) 
 142 (135-
150) 
139 (134-
144) 
164 (159-
169) 
153 (145-
161) 
7 (53) 154 (123-
185) 
    
7.0-7.49 
(53-58) 
 152 (143-
162) 
152 (147-
157) 
176 (170-
183) 
177 (166-
188) 
7.5-7.99 
(58-64) 
 167 (157-
177) 
155 (148-
161) 
189 (180-
197) 
175 (163-
188) 
8 (64) 183 (147-
217) 
    
8.0-8.5 (64-
69) 
 178 (164-
192) 
179 (167-
191) 
206 (195-
217) 
222 (197-
248) 
9 (75) 212 (170-
249) 
    
10 (86) 240 (193-
282) 
    
11 (97) 269 (217-
314) 
    
12 (108) 298 (240-
347) 
    
 
 Table 2.1 above shows the relationship between HbA1c and mean glucose level 
for diabetic patient compiled by the American Diabetes Association (ADA). The table 
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above is used by clinician for glycemic control purposes; clinician uses the A1c to 
determine the appropriate glucose level for fasting, premeal, postmeal and before 
bedtime. The mean glucose level is based on the data of 507 adults that either has type 1 
diabetes, type 2 diabetes and no diabetes; the association also mentioned that 2700 
readings was taken per A1c column. The table above was not being taken into 
consideration in designing the fuzzy logic system because it is not reliable; in the same 
report, the ADA mentioned that “in a recent report, mean glucose [level] measured with 
CGM [continuous glucose monitoring] versus central laboratory-measured A1c in 387 
participants in three randomized trials demonstrated that A1c [laboratory measured test] 
may underestimate or overestimate mean glucose” (p. 557) even though the association 
has determined that there are strong correlation (r=0.92) between the HbA1c and mean 
glucose level. Furthermore, it only shows the normal range of patient’s blood glucose 
level and not range for hyperglycemia or hypoglycemia. The association suggested that 
blood monitoring device integrated with control strategy (i.e. continuous glucose 
monitoring) has the potential to help diabetic patient in improving their glycemic 
management.  
2.4 Fuzzy Logic 
 
 Fuzzy logic is one of the branches that make up artificial intelligence. It was 
introduced by Lofti Zadeh, a researcher in the department of computer science at the 
University of California, Berkeley. Fuzzy logic is used to solve problems that has no 
definitive yes/no or black/white answer; in essence, system incorporated with fuzzy logic 
has the capabilities to obtain definitive solution based on vague and imprecise data (Grant, 
2007). 
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Figure 2.1: Example of Fuzzy Logic Graph (Maplesoft) 
 
 Fuzzy logic utilized multi valued logic instead of the binary Boolean logic and it 
is represented in the y-axis as shown in figure 2.1; the y-axis is called the degree of 
membership. The x-axis is called the universe of discourse; it is the range of all possible 
value of chosen variable. The graph in the figure 2.1 is called the membership function 
and it defines how each value of the universe of discourse is correlated to the degree of 
membership. For instance, people who are 180 cm is considered “sort of” tall because its 
degree of membership is 0.6 while people who are 190 cm is considered tall because 
degree of membership is 1. In terms of the shape of the membership function, it can be of 
any shape but the triangle, trapezoidal, and bell shape are most commonly used.  
 In addition to graph, fuzzy logic system also utilizes linguistic variable to 
represents the universe of discourse of the input and output variable in linguistic term. 
For instance, the range from figure 2.1 can be described linguistically as short, slightly 
tall, sort of tall, and tall for the 100-160, 160-169, 170-189, and 190-200 cm range, 
respectively. The linguistic representation of the value is called hedges. Turning the range 
of the input and output variables into linguistic variable is important in order to create 
fuzzy rule (linguistic rule). 
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Figure 2.2: Basic Fuzzy Logic Model 
 
 Based on the example shown above, it can be deduced that fuzzy logic system 
requires input variables, output variables, linguistic rule and membership function. Figure 
2.2 above shows the basic process of fuzzy logic system. The input variables can be more 
than one and the linguistic rule comes in the form of IF-THEN rule. For example, the 
100-160 cm range is considered short, so the linguistic rule is written as “if the height is 
100-160, then the person is short”. The example shown in figure 2.1 is a basic fuzzy logic 
example; more complicated fuzzy logic system involves more than one membership 
function in one input and multiple linguistic rule.  
 
 
 
 
Figure 2.3: Mamdani Method 
 
In fuzzy logic system, the numerical value of the input variables will be fuzzified, 
meaning that the crisp number will be inserted into its appropriate fuzzy sets in order to 
determine its degree of membership; but the output of the fuzzy logic system need to be 
in a crisp number; thus, the fuzzified input will need to undergo defuzzification. There 
are two methods that can be used for defuzzification purposes; one of the methods are the 
Crisp 
input 
Fuzzification Rule 
Evaluation 
Aggregation 
Defuzzification Crisp 
output 
Input Fuzzy Model 
Linguistic rule 
Output 
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Mamdani method and the other is Sugeno method. For this project, the Mamdani method 
will be used. Flow chart above shows the fuzzification-defuzzification process using 
Mamdani method. As mentioned above, the crisp input will first be fuzzified. The next 
step is to determine the linguistic rule; if there is more than one antecedent (i.e more than 
one input), the AND/OR operator can be applied. The OR operator represents a union or 
the maximum value among the fuzzified input; it is used to determine the disjunction of 
the rule antecedents. In contrast, the AND operator represents an intersection or the 
minimum value among the fuzzified input and it is used in order to determine the 
conjunction of the rule antecedents. After determining and implementing the operator, 
the maximum/minimum value is correlated to the consequent (output) membership 
function via clipping method. For example, if the fuzzified input of A and B are 0.1 and 
0.2, respectively, and the linguistic rule uses AND operator, then the fuzzified output is 
0.1. The example given represents only one fuzzified output and in fuzzy logic system 
there are more than one output because more than one linguistic rules are required to 
mimic the real life condition; thus, all the rule’s output will be aggregated into a single 
fuzzy set. Finally, the fuzzified output is defuzzified by using the centroid technique; the 
technique basically divides the output fuzzy set into two equal areas. The point that 
divides the area is the crisp output of the fuzzy system. 
 
 
 
 
 
Figure 2.4: the “General Scheme of Identification Procedure” (Vachov, 2000, p. 
52) 
 
Input 
Real Process 
Fuzzy 
Model 
Error 
Identification 
algorithm 
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 Identifying the number of input and output variable and determining the linguistic 
rule of the system require knowledge of the subjects and implementing iterative learning 
algorithm so that the system best mimic the real process. Figure 2.4 above shows the 
iterative process to mimic the real process. It shows the process of identifying and 
changing the input, output, and linguistic rule by minimizing the error of the fuzzy model; 
the procedure is done by comparing it with the real process and then identification 
algorithm will determine where the error occurs. There are three level of identification 
that can be utilized to minimize the error between the real process and fuzzy model. The 
first level is the structure identification; in this level, the number of linguistic rule (i.e IF-
THEN rule) and the number of input variable is adjusted. It is on this level where addition 
or reduction of linguistic rule and input variable is considered. The next level is the 
antecedent parameters identification, where the shape and range of the membership 
function will be adjusted; the former and the latter are fine-tuned so that it can correctly 
represent the linguistic rule in numerical terms. The final level is the consequent 
parameters identification; this level determines the number of output and identifying the 
range and shape of the membership function of the fuzzy model (Vachov, 2000).  
 The next subsection will first introduce the application of fuzzy logic in medical 
field followed by the application of fuzzy logic in monitoring diabetic patients. 
2.4.1 Fuzzy Logic Application in Medical Field 
 
 Many medical devices have incorporated fuzzy logic theory into its system to 
increase the efficiency of healthcare providers in monitoring their patient; for instance, 
fuzzy logic system has been incorporated into anaesthetic monitoring device to help 
improve anaesthetist performances. Mirza and GholamHosseini (2010) lamented that 
“human errors in anaesthesia account for more than 80% of the preventable mishaps” (p. 
3974). This mainly because anaesthetist depends on their experience and intuition when 
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making decisions and in most of the circumstances, these “intuitive decision-making fails 
to achieve the optimal balance under competing or conflicting care delivery demands” (p. 
3974). There is built-in alarm in medical devices that helps anaesthetist monitor the 
patient, but the system rigidity sometimes causes error that might harm patients. Mirza 
and GholamHosseini mentioned that “the frequent alarms are not only a nuisance for 
patients and caregivers but can also compromise patient safety and the effectiveness of 
care” (p. 3975). The rigidity of the classical system is mainly due to its dependent on 
exact mathematical analysis. 
Table 2.2: Standard Deviation for Hypovolaemia (Mirza and 
GholamHosseini,2010, p. 3976) 
Hypovolaemia Mild Moderate Severe 
Heart Rate (SD) 1.75-3 3-5 5 & > 
Blood Pressure (SD) 2.75-5 5-6 6 & > 
Pulse Volume (SD) 4-6 6-8 8 & > 
 
 Fuzzy logic theory was used to solve the rigidity of the classical system; with the 
implementation of fuzzy logic, the medical device has the capabilities to strategize that 
resembles human strategic thinking. This system is called fuzzy logic monitoring system 
(FLMS); the system was developed by using Matlab’s fuzzy logic tool box. The three 
physiological parameters that it measured are heart rate (HR), blood pressure (BP), and 
pulse volume (PV). The system detects and classify hypovolaemia into three stages; the 
stages are mild, moderate and severe. In order to test the system, the first was step was to 
obtain patients’ data; it was obtained from an anaesthesia monitor called S/5 Datex-
Ohmeda located in the operating theatre; data acquisition from the monitor was approved 
by the local ethics communities. Then, the data was converted into digital format via 
DOMonitor.net. The various intra-operative procedures occurred during anaesthetic 
resulted in the raw digital data’s waveforms incur high noise content; filtering technique 
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such as variance-based filtering, low pass filtering and threshold-based noise rejection 
was used to filter the noise. After the filtration of noise, the system will be ready to be 
configured; there are 3 principles the system will follow before the system’s alarm turned 
on. These 3 principles are in order; the first principle makes sure that the system will only 
accept HR, BP and PV input; system will announce alarm status as false if one of the 
inputs is missing and it will wait for the next data set that is obtained for the next 15 
minutes. The second principle is setting limitation on the membership functions. The 
limits are classified as mild, moderate, and severe by calculating the standard deviation 
values for each parameter; table 2.2 above shows the standard deviation value of all three 
inputs classified as mild, moderate, and severe. This classification is done after the system 
is trained to analyse the input of 10 model patients’ data and testing it with 10 random 
patients’ data by using adaptive neuro fuzzy inference system technique; figure 2.5 below 
shows the FLMS structure. If both first and second principle are true (i.e. all three inputs 
are present and parameter exceed the SD limit), then principle 3 will check the validity 
of the system by applying the IF-THEN rule as shown in figure 2.6. The results shown in 
FLMS will then be compared with anaesthetist via Kappa analysis. Early research shows 
the system in agreement with anaesthetist majority of the time, but the author suggest 
more research is needing to increase the validity of the result. 
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Figure 2.5: Fuzzy Logic Monitoring Structure (Mirza and GholamHosseini, 
2010, p. 3976) 
 
 
Figure 2.6: IF-THEN Rule Structure (Mirza and GholamHosseini, 2010, p. 3976) 
 
Similarly, de Schatz (2015) uses fuzzy-neural based tool to monitor and predict 
patients’ condition (p. 2580). Although the research done by de Schatz focused on patients 
under the intensive care unit, the method used is applicable to diabetic patient. Neural 
network is a branch of artificial intelligence where the computer system mimics the 
learning behaviour of human brain by feeding the system with data. Integrating fuzzy 
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logic with neural network will increase the capabilities of the system, but the system will 
have both the drawbacks of neural network and fuzzy logic. In addition to the drawbacks 
of fuzzy logic, Adidela, Devi, Suma and Allam (2012) mentioned that the process of 
developing artificial neural network is complex and requires knowledge from expert in 
the field of artificial intelligence. 
The anaesthetic monitoring device was reviewed extensively here because even 
though anaesthetic monitoring is not relevant in monitoring blood glucose level, the 
technique used to monitor heart rate, blood pressure, and pulse volume is applicable in 
monitoring blood glucose level. 
2.4.2 Fuzzy Logic Application in Diabetes 
 
 Research has been done in trying to apply Grant (2007) proposed an approach to 
incorporate fuzzy logic to monitor and maintain patient’s blood glucose level. Figure 2.7 
shows the engineering diagram of a closed loop feedback system. 
 
Figure 2.7: Closed Loop Feedback System for Diabetic Monitoring Device 
(Grant, 2007, p. 826) 
Grant mentioned that some patients able to withstand high or low blood glucose 
level while some patients does not have the capabilities to do so; thus, the monitoring 
device that incorporate closed loop feedback system as shown in figure 2.7 will be able 
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to solve problem mentioned above. The closed loop feedback system will recognise 
changes occur in blood glucose level. When changes occur, blood monitoring sensor will 
send the data to the fuzzy logic control system and the system will decide the optimal 
insulin infusion rate needed to be pumped into patients’ system or it will not do anything 
if it’s a false alarm. The key issue with Grant’s article is it did not present the technology 
that it used to utilize the fuzzy logic system. Knowing the program or application used is 
important to estimate the cost of creating the simulation and eventually obtaining the 
necessary license to use the technology in a physical product.  
In contrast with Grant, Adidela et al. (2012) included the technology used to 
monitor blood glucose level. Adidela et al. (2012) proposed a more advanced fuzzy logic 
algorithm called Fuzzy ID3; it is an “extension of ID3 (The Interactive Dichotomizer 3) 
technique…[and] it is most widely used decision tree algorithm” (p. 542). While the 
incorporation of fuzzy logic system into diabetes monitoring device will greatly improve 
patients’ life, Adidela et al cautioned that proficiency in fuzzy logic theory is needed to 
develop the system. The main difficulty in applying Adidela et al. (2012) technique is the 
need to understand the abstract mathematics presented in the article; thus, developer and 
physician need to be proficient in abstract mathematics in order to use the Fuzzy ID3. 
The differences between this project and those mentioned above is that this project 
will use Matlab’s fuzzy inference editor to create the fuzzy logic system for blood glucose 
monitoring. Using programming language such as Matlab will help in simplifying the 
fuzzification and defuzzification steps and developer does not necessary need advanced 
mathematical knowledge to develop the fuzzy logic system. 
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2.5 Artificial Pancreas 
 
 Artificial pancreas is a technological device that can help improves the life of 
diabetic patients.  It is the integration of sophisticated control strategy such as fuzzy logic 
to monitor blood glucose level. All of the artificial pancreas is currently in the clinical 
stage, pending FDA approval. The differences between each artificial pancreas is the 
control strategy used to monitor patient’s blood glucose level; for instance, Dassau et al 
(2017) uses G4 Share AP [Artificial Pancreas] with 505 algorithm developed by Dexcom, 
a company based in San Diego, California. The system shows promising result; after 12 
weeks of using the artificial pancreas device, it was found that all 29 patients showed 
improvement in their HbA1c percentage. HbA1c percentage is the percentage of non-
enzymatic attachment of glucose to proteins, in this case the haemoglobin found in human 
blood and it is directly proportional to patients’ blood glucose level. The only issues with 
the method used by Dassau et al is the cost of the technology used in this research and it 
will take longer time for the technology to reach 3rd world countries. 
 Khan, Masud, and Mamun (2017) proposed a method that can help patient manage 
their blood glucose level in a novel, efficient and in convenient ways; this was done by 
using mathematical models and patients’ previous self-monitoring blood glucose value to 
predict patients blood glucose value on the next day. The mathematical models used are 
support vector regression model, linear regression model, and Weilbull distribution 
model. The accuracy of all three predictions model were compared to each other by using 
root mean square error. Based on the root mean square error calculated, Khan et al were 
not convinced that all three mathematical models yield accurate prediction. The main 
reason why predictions were not accurate is because data used for this research came from 
the UCI machine learning repository; It was indicated in the article that data variation is 
one of the main reasons why all three mathematical models yield different prediction. 
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Khan et al believes that all three of their models will work if they are used in real data 
from patients and they will initiate the research in the near future. Once the research is 
complete, Khan et al plans to develop an app that will incorporate one of the prediction 
models. One of the main weaknesses found in Khan et al methods are the mathematical 
model used are complicated and unnecessary when emerging method such as machine 
learning will soon be readily available and able to monitor blood glucose level in a much 
more efficient manner. 
 Recently, there is growing application of machine learning method towards blood 
glucose monitoring; for instance, Sudharsan B et al. uses Random Forest, support vector  
machines (SVM), k-nearest neighbour, and naïve Bayes to predict hypoglycemia for type 
2 diabetes patient (as cited by Kavakiotis et al., 2017, p. 109). Similarly, George et al. 
(2013) uses support vector regression to predict hypoglycemia. While the findings of both 
Sudharsan B et al. and George et al. are promising, it only able to predict hypoglycemic 
cases and not hyperglycemia. 
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CHAPTER 3: METHODOLOGY 
 
3.1 Introduction 
 
 This chapter highlight the steps taken to design the fuzzy logic system for the 
purpose of monitoring blood glucose level. First, the variables that need to be included in 
the fuzzy logic system is discussed. Then, it is followed by the step by step process of 
implementing variable and linguistic rule into Matlab’s fuzzy inference editor. Finally, 
the method in obtaining the data is discussed. 
3.2 Design Criteria 
 
 The main purpose of designing the fuzzy logic system is to eventually be 
implemented in a non-invasive blood monitoring device for diabetic patient to monitor 
their blood glucose level for daily usage; thus, only relevant variables were included in 
developing the fuzzy logic system for this project. In subsection 3.2.1, the method in 
obtaining the variables is discussed; furthermore, the basic diabetes monitoring flowchart 
is shown in figure 3.1. 
3.2.1 Variable 
 
 Determining the input variable is important in order to determine whether a 
diabetic patient experienced hypoglycemia or hyperglycemia. The most important 
variable is the blood glucose level; the range of blood glucose level will correspond to 
the action that diabetic patient will take (i.e. inject more or less insulin and/or visit their 
doctor). According to American Heart Association, the blood glucose range in 
determining whether a diabetic patient has hyperglycemia depends on prescription by 
doctor; thus, it is difficult to generalize the blood glucose range because each individual 
diabetic patient may have different range. For the purpose of this project, the blood 
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glucose range to diagnose diabetic patient was used. The range of the blood glucose level 
can be easily change depending on clinician prescription. 
Furthermore, the relationship between blood glucose level and patients 
experiencing hyperglycemia depends on whether patient is fully nourished or fasting. 
According to the American Diabetes Association (ADA), patient need to measure their 
blood glucose level before and after meal, before bedtime, and when they are fasting (“6: 
Glycemic Target: Standards of Medical Care in Diabetes -2018”, 2018); thus, the second 
variable that need to be included is the time after a patient has their meal. Table 3.1 below 
shows the blood glucose range for fully nourished and fasting diabetic patient and the 
corresponding dependent variable. 
Table 3.1: Blood Glucose Range for Fasting and 2 hours Glucose Tolerance Test 
(WHO) 
conditions Hypoglycemia 
(mg/dl) 
Normal 
(mg/dl) 
Impaired 
Glucose 
tolerance 
(mg/dl) 
Hyperglycemia 
(mg/dl) 
Fasting ≤ 72 74-109 110-125 ≥126 
2 hours 
Glucose 
Tolerance 
Test 
≤ 72 73-139 140-199 ≥200 
 
 As mentioned above, monitoring blood glucose level of a diabetic patient depends 
on whether the patient is fasting or fully nourished; higher blood glucose level is 
considered normal in the first 2 hours after meal. Figure 3.1 below shows the flowchart 
in monitoring diabetic patient’s blood glucose level. 
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Figure 3.1: Basic Diabetes Monitoring Flowchart 
 Other variables that were taken into consideration but not included in the 
simulation were HbA1c (glycated haemoglobin), systolic blood pressure, and body mass 
index. HbA1c was not included because the purpose of this simulation is to eventually be 
able to integrate the fuzzy system with self-monitoring or continuous glucose monitoring 
device that will be used at home. Furthermore, HbA1c check-up is mainly done by doctors 
and it is dependent on the situation of the diabetic patient; for instance, some patient who 
managed to effectively control their blood glucose level will only require 4-6 times 
HbA1c check-up per year while some will require regular (weekly or monthly) check-up 
Start 
Did patient eat 
any meal for 
the last 2 hour? 
2 hour-post 
prandial 
range 
Fasting blood 
glucose range 
yes no 
Check for hypoglycemia 
or hyperglycemia 
End 
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(HAP.org). Systolic blood pressure was not included because it is the dependent variable 
of patient’s blood glucose level, specifically between hypoglycemia and increasing blood 
pressure; Feldman-Billard et al. (2010) mentioned that for type 2 diabetic patient 
experiences an increase in systolic blood pressure 20-30 minutes after hypoglycemic 
event. In relation to type 1 diabetes, it is still debatable whether the hypoglycemic event 
has an effect on systolic blood pressure (829). As mentioned in the literature review 
section, even though there is a strong correlation between high body mass index and 
diabetes, not all obese patient is diabetic. Thus, BMI index was not included as the input 
variable. 
3.3 Simulation Steps 
 
 This section will demonstrate the process of designing fuzzy logic system for 
diabetic monitoring via matlab. 
Steps 
1.  Open the Matlab software. 
2. Open the fuzzy logic toolbox by typing “fuzzy” on the command window as shown in 
figure 10 below 
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Figure 3.2: Command Window in Matlab 
3. Fuzzy Inference System (FIS) editor will appear as shown in the image below. Adjust 
the number of input and output accordingly. For this project, there are two input and one 
output. 
 
Figure 3.3: Fuzzy Inference System Editor 
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4. The universe of discourse for both inputs is shown in table 3.2 and 3.3, respectively. 
Table 3.2: Range for Blood Sugar (mg/dl) 
Blood sugar (mg/dl) Condition (level) 
0-79 low 
73-140 normal 
125-199 caution 
≥ 185 high 
 
Table 3.3: Time After Meal (hour) 
hour condition 
0-3 full 
2-5 Slightly hungry 
4-8 hungry 
 
5. After filling the range of the inputs, the membership function’s shape was determined. 
As shown in figure 3.4, the shape for blood sugar input are trapezoidal. The degree of 
membership is 1 until it reaches a certain point where fuzziness occurs; for example, 0-
72 mg/dl is considered low but 73-79 is between low and normal level. The membership 
function’s shape for time after meal is not uniform as compared to blood glucose level 
membership function. As shown in figure 3.5, the membership function’s shape for time 
after meal consist of half triangle, an obtuse triangle, and trapezoidal. The shape mimics 
the condition of human hunger situation; the degree of membership for the first 
membership function (half triangle) indicate that there is no fuzziness whether patient is 
hungry 0 hours after meal, then the degree of freedom is slowly changes (lowered) until 
it reaches 3 hours after meal, where patient will start to experience slight hunger or the 
feeling of fully satiated is gone. As with the previous membership function, the feeling 
of slight hunger will be true up to certain point; for most individual, they may start 
experiencing it in between 4 to 5 hours after meal. The final membership function is 
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trapezoidal in shape and it starts at 4 hours after meal; this is to take into consideration 
that some patient has high metabolism and thus will experience hunger much more 
quickly, yet it is still in the fuzzy region because it is not always true. For most individuals, 
regardless whether diabetic or non-diabetic patient, will start to feel hungry from 6 hours 
after meal onwards; thus, degree of freedom from 6 hours onward is 1.  
 
Figure 3.4: Membership Function for Blood Glucose Level 
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Figure 3.5: Membership Function for Time After Meal 
6. The universe of discourse for the output is shown in table 3.4 and the membership 
function plot is shown in figure 3.6. 
Table 3.4: Output Range for Patient's Condition 
Condition Level 
hypoglycemia 0-3 
normal 2.5-5.5 
Pre-diabetic 5-8 
hyperglycemia 7.5-10 
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Figure 3.6: Membership Function for Patient Condition 
7. After filling both the input and output, the type of method needs to be determined. The 
method used for this project is the Mamdani method. The defuzzification is done by using 
the centroid technique. 
8. After filling both the input and output, the next step is to insert the linguistic rule into 
the system.  The linguistic rule is shown below 
I. If Blood Glucose is low and hour after meal is full, then patient has hypoglycemia 
II. If Blood Glucose is low and hour after meal is slightly hungry, then patient has 
hypoglycemia 
III. If Blood Glucose is low and hour after meal is fasting, then patient has 
hypoglycemia 
IV. If Blood Glucose is normal and hour after meal is full, then patient is normal 
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V. If Blood Glucose is normal and hour after meal is slightly hungry, then patient is 
pre-diabetes 
VI. If Blood Glucose is normal and hour after meal is hungry, then patient has 
hyperglycemia 
VII. If Blood Glucose is caution and hour after meal is full, then patient is pre-diabetic 
VIII. If Blood Glucose is caution and hour after meal is slightly hungry, then patient is 
pre-diabetic 
IX. If Blood Glucose is caution and hour after meal is fasting, then patient has 
hyperglycemia 
X. If Blood Glucose is high and hour after meal is full, then patient has 
hyperglycemia 
XI. If Blood Glucose is high and hour after meal is slightly hungry, then patient has 
hyperglycemia 
XII. If Blood Glucose is high and hour after meal is fasting, then patient has 
hyperglycemia 
9. Figure 3.7 below shows the linguistic rule on the matlab’s software 
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Figure 3.7: Linguistic Rule Input 
10. To retrieve the file, open the fuzzy logic toolbox on Matlab and click the file 
button. Then, click the import button and search for the file. 
 
 
 
 
 
 
 
 
 
 
30 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8: Flowchart for Setting Up and Analyse the System 
Open Matlab 
software 
Type “fuzzy” on 
command window 
Determine method and 
number of input and 
output 
Determine 
linguistic rule 
Determine Universe of 
Discourse for input and 
output 
Determine the shape 
of membership 
function 
Analyse result 
Output is 
reasonable
? 
yes 
Collect 
data 
no 
Change relevant error 
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11. Figure 3.8 above shows the flowchart of the process in designing and analysing the 
output of the system. The flowchart represents brief summary of the step taken above in 
designing the system. Furthermore, it also shows the iterative step taken in improving the 
system so that it can best mimic the real condition. If the output is not reasonable, then 
the system will be re-analysed in order to determine the error of the system; the error 
could come from insufficient linguistic rule, wrong universe of discourse (range) for the 
input and output variable, inaccurate membership function or all of them combined. 
3.4 Collecting Data 
 
 The result developed by the system can be viewed as surface viewer or rule-based 
window as shown in figure 3.9 and 3.10, respectively. The surface viewer represents the 
relationship between the input and output. In figure 3.9, the x and y axis represent blood 
glucose and hour after meal while z axis represents patient’s condition. By choosing any 
value from blood glucose level and time after meal, the graph can be used to find the 
condition of the patient. But throughout the project, the rule-based window was used to 
obtain data. The value of blood glucose level and time after meal is change by adjusting 
the red line on both the input variable; the condition will correspond to the change made 
by the adjustment the blood glucose level and/or time after eaten variable. Alternatively, 
both the input value can be adjusted by changing the input value manually via the input 
column. 
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Figure 3.9: Surface Viewer Window 
 
Figure 3.10: Rule Viewer Window 
 
33 
 
CHAPTER 4: RESULT AND DISCUSSION 
 
4.1 Introduction 
 
 This chapter will discuss the result obtained from the fuzzy logic system; 
furthermore, it will discuss about the integration of the system with blood glucose 
monitoring device and insulin pump to form an artificial pancreas. Then, it will discuss 
about the benefits of artificial pancreas and the effect of technological advancement 
towards diabetes monitoring. 
4.2 Result 
 
 Table 4.1 below shows 12 random data obtained after initially setting up the 
system on Matlab. The screenshot of the data obtained from Matlab as shown on the table 
can be found on the appendix. The output was then compared to the real condition based 
on table 3.1 in chapter 3. For instance, between 0-2 hours after meal the 2 hours glucose 
test will be used as comparison and the fasting glucose test will be used as comparison 
for ≥ 4 hours after meal. 
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Table 4.1: Result Obtained from the System 
Number Blood 
Glucose 
time output condition Real condition 
1 67.7 0.136 1.4 hypoglycemia hypoglycemia 
2 67.7 3.59 1.43 hypoglycemia hypoglycemia 
3 67.7 8.05 1.4 hypoglycemia hypoglycemia 
4 130 0.136 5.1 normal normal 
5 130 3.32 6.51 Pre-diabetic Normal/pre-
diabetic 
6 130 7.77 8.86 hyperglycemia hyperglycemia 
7 212 0 8.9 hyperglycemia hyperglycemia 
8 212 4.5 8.88 hyperglycemia hyperglycemia 
9 212 8.05 8.9 hyperglycemia hyperglycemia 
10 125 5 7.01 Pre-diabetes Pre-diabetes 
11 125 7.86 8.9 hyperglycemia Quasi-
hyperglycemia 
12 37.8 0.0455 1.4 hypoglycemia hypoglycemia 
 
 Based on the preliminary data, the system performed well relative to the real 
condition, with the system yielding 83% accuracy rate; for instance, the output of data 1 
to 3 correctly show that patient experiencing low blood sugar level is experiencing 
hypoglycemia, regardless whether patient just consumed their meal or they are fasting. 
The output for data 1,2, and 3 are 1.4,1.43, and 1.4, respectively; based on the output 
range outlined in table 4.1, all three value dictates that patient is experiencing 
hypoglycemia and the hypoglycemia membership function from figure 3.6 shows that the 
degree of membership for all three data is 1; this indicate that there is no fuzziness and 
that patient is experiencing hypoglycemia.  Similarly, the output for data 7,8, and 9 
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correctly shows that patient who has high blood sugar level is experiencing 
hyperglycemia, regardless of whether he/she just consumed their meal or they are fasting. 
The output value for data 7,8, and 9 are 8.9,8.88, and 8.9, respectively; based on the 
hyperglycemia membership function shown in figure 3.6, the degree of membership for 
all the three data is 1, meaning that there is no doubt that patient is experiencing 
hyperglycemia. 
The only error occurred in data 5 and 11. In terms of data 5, it lies in the region 
between fully satiated and hungry (time after meal is 3.32 hours). The condition based on 
the output is 6.51, indicating pre-diabetic; but the real condition is difficult to decipher 
because it’s in the slightly hungry range; the real condition could be in between 
normal/pre-diabetic range. For data 11, 125 mg/dl and 7.86 hour after meal is still 
considered to be in pre-diabetic region, but it is entering the hyperglycemia region as the 
value of hyperglycemia for fasting is 126 mg/dl and above. Thus, the output value should 
be on the region of pre-diabetes (5-8), or more specifically between 7.5-8, which is the 
fuzzy region between pre-diabetes and hyperglycemia (quasi-hyperglycemia); yet the 
output value for data 11 is 8.9, indicating it’s a hyperglycemia condition with degree of 
membership of 1.  
 The small error occurred is mainly due to the blood glucose level range and/or 
knowledge base (linguistic rule) input. To further analyse the system, data of blood 
glucose level at 126 mg/dl and 140 mg/dl at various time after meal was used. The main 
reason the former and latter were picked is because both of the value represent different 
condition at different time; for instance, 126 mg/dl blood glucose level is considered 
normal for fully satiated diabetic patient but hyperglycemic for fasting diabetic patient. 
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Table 4.2: Results for 126 and 140 mg/dl at Various Time 
Data Blood 
Glucose 
Level 
(mg/dl) 
Time 
after 
meal 
(hr) 
Output Condition Real Condition 
1 126 0 4.27 normal normal 
2 126 4 6.51 Pre-diabetic Normal/pre-diabetic 
3 126 8 8.89 hyperglycemia hyperglyemia 
4 140 0 6.51 Pre-diabetic Pre-diabetic 
5 140 4 6.51 Pre-diabetic Pre-
diabetic/hyperglycemia 
6 140 8 8.9 hyperglycemia hyperglycemia 
7 126 3.25 6.51 Pre-diabetic Normal/pre-diabetic 
8 126 9.2 8.89 hyperglycemia hyperglycemia 
9 140 3.25 6.51 Pre-diabetic Pre-diabetic 
10 140 9.2 8.9 hyperglycemia hyperglycemia 
 
 Based on table 4.2 above, there were irregularity between the system condition 
and real condition when time after meal is between 3 to 4 hours. The output for data 2 
and 7 is 6.51, which indicate that patient is experiencing pre-diabetic condition. But the 
real condition is difficult to decipher because the range is in between after the 2hr glucose 
tolerance test and before fasting (hungry) range. In the fuzzy logic system, 4 hours after 
meal indicates that a patient is slightly hungry, but the digestion of food depends on 
patient’s metabolism and the metabolism of diabetic and non-diabetic patient are almost 
similar (diabetes.co.uk.); thus, some patient may be experiencing pre-diabetic while other 
is still in normal range.  The same conclusion is true when blood glucose level is at 140 
mg/dl; at 3-4 hours after meal, the system predicted that the patient is in the pre-diabetic 
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range. But the real condition indicate that patient might be in between pre-diabetic and 
hyperglycemia range, depending on their metabolism. 
 The main weakness of the system is it did not take physical activities into 
consideration; the intensity of patient’s physical activities has an effect towards their 
metabolism. Before developing system, it was assumed that patient will only perform low 
intensity physical activities and thus the effect of metabolism should be negligible; but it 
was later found that there are athlete who has diabetes, usually type 1 diabetes. The 
proposed solution is to add another input that represents the physical activities, but in 
order to do so, a deep knowledge in the field of sport science, nutrition, and metabolic 
biology are needed; in other word, the input of expert such as nutritionist, sport scientist, 
and doctors are required.  
4.3 Integration of fuzzy logic system 
 
 The main purpose of this research project is to run a simulation of fuzzy logic 
system to monitor blood glucose level. At some point in the future, the findings from this 
project can be integrated with a blood glucose monitoring device and insulin pump to 
form an artificial pancreas. Flowchart below shows how a blood glucose monitoring 
device integrated with control strategy such as fuzzy logic system and insulin pump to 
monitor diabetic patient’s blood glucose level. 
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Figure 4.1: Flowchart for Artificial Pancreas Functionality 
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4.4 Benefits and Challenges of Artificial Pancreas 
 
 The integration of blood glucose monitoring device, insulin pump and a control 
strategy are invariantly called artificial pancreas. Fuzzy logic system developed for this 
research project is one of many control strategies that can be used for the purpose of 
monitoring and maintaining optimal blood glucose level for diabetic patient. 
 Most of the research done in regards to artificial pancreas is still in clinical stage, 
but research done so far indicates the likelihood of artificial pancreas to replace the 
conventional method; for instance, Dassau et al. (2017) designed and conducted a study 
that tracks the performance of artificial pancreas in monitoring and maintaining blood 
glucose level in 29 type 1 diabetes patients. The studies lasted for 12 weeks and all 29 
subjects used artificial pancreas to monitor and maintain their blood glucose level; 
subjects have to use the artificial pancreas 24/7 throughout the studies. The unique feature 
of the artificial pancreas designed by Dassau et al is the integration of controlling 
algorithm and cloud-based server into the devices; thus, patients’ data will be 
automatically uploaded into the server. Based on the data, each patients’ basal insulin 
delivery settings will be changed each week. 
 After 12 weeks of using the artificial pancreas device, it was found that all 29 
patients showed improvement in their HbA1c percentage. HbA1c percentage is the 
percentage of non-enzymatic attachment of glucose to proteins, in this case the 
haemoglobin found in human blood and it is directly proportional to patients’ blood 
glucose level. According to World Health Organization, a person is considered diabetic 
if their HbA1c percentage is 6.5% or above. In the article, subjects HbA1c improved from 
averaging 7.0 ± 0.8% to 6.7% ± 0.6% after 12 weeks of using the artificial pancreas 
device. Even though it is still in the diabetic range, it showed a promising potential in 
maintaining patients’ blood glucose level. Furthermore, the studies showed that subjects 
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spent less time in the hypoglycemic range while using the artificial pancreas. Even though 
the system showed promising potential, it is still not yet perfect; Dassau et al. (2017) 
mentioned in the article that “10% of adaptation recommendation were manually 
overridden” (p. 1719).  
 Even with the initial success that artificial pancreas received, it is still not readily 
adaptable for recreational purposes; Turksoy et al. (2017) mentioned that monitoring 
blood glucose level while performing physical activities can be a major challenge in the 
development of artificial pancreas. Thus, it was proposed that biometric physiological 
variables such as heart rate, heat flux, skin temperature, near-body temperature, and 
galvanic skin response be included in the artificial pancreas system; the main objective 
was to find which biometric physiological variables has the strongest correlation with the 
changing of blood glucose level (Turksoy et al., 2017). The correlation was tested by 
using partial least square (PLS) regression and variable importance in projection (VIP) 
method. Out of all listed biometric physiological variables above, skin temperature was 
found to have the strongest correlation with blood glucose level. Turksoy et al. (2017) 
suggested that skin temperature should be considered to be included into artificial 
pancreas system. 
Although most of the research associated with artificial pancreas lean towards 
type 1 diabetes patient, there are recent studies conducted in the application of closed loop 
artificial pancreas on type 2 diabetes patient. As mentioned above, Khan et al (2017) 
argues that continuous glucose monitoring and thus artificial pancreas is not compatible 
with type 2 diabetes “because of the fact that Type 2 diabetes patients are more likely to 
measure their BGL with self-monitoring blood glucose (SMBG) which are taken once or 
twice daily at home by the patients themselves” (p. 392). But researchers from the 
University of Cambridge did not agree to the argument proposed by Khan et al; 
Kumareswaran et al (2014) conducted a feasibility studies in regards to the application of 
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closed loop insulin delivery on type 2 diabetes patient. In the article, Kumareswaran et al 
used the word closed loop insulin delivery to describe their method instead of artificial 
pancreas even though it is identical. The research conducted by Kumareswaran et al was 
initiated by having 12 subjects with type 2 diabetes to undergo two 24 hours visit; subjects 
underwent closed loop insulin delivery on their first visit while on the second visit 
subjects underwent a controlled treatment in which patients was treated via conventional 
method. 7 of the subjects are male with an average age and BMI to be 57.2 years and 30.5 
kg/m2, respectively; the average years of subjects having diabetes is 7.6 years.  The result 
of both the closed loop and controlled treatment were then compared to each other; the 
feasibility study showed that using closed loop insulin delivery (artificial pancreas) 
increases the time (40% in 24 hours) that blood glucose level stays in normal range as 
compared to patient that did not used the closed loop insulin delivery (24% in 24 hours). 
In addition to that, there is no apparent risk of subjects having hypoglycemia when 
subjects underwent the closed loop insulin delivery therapy. Kumareswaran et al. (2014) 
mentioned that the most significant discovery obtained from the studies is the “overnight 
glycemic control [blood glucose range when subjects were asleep] achieved with closed-
loop system was comparable to that previously shown in adults with type 1 diabetes (time 
in target 78 vs 76%)” (p. 1201). Even though the overall glycemic control (time in normal 
blood glucose range) between type 1 and type 2 diabetes patient is slightly different, the 
similarity in overnight glycemic control indicates that artificial pancreas may be suitable 
for type 2 diabetes patient; at the same time, more research is still need to be done in the 
compatibilities of artificial pancreas with type 2 diabetic patient.  
Khan et al. proposed argument on the incompatibilities of artificial pancreas with 
type 2 diabetes patient occurs three years after the feasibility studies was conducted by 
Kumareswaran et al, yet the latter’s article was not mentioned in the former’s reference. 
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Thus, it can be concluded that Khan et al may not be aware of the research done by 
Kumareswaran et al.  
4.5 Improvement of Diabetes Monitoring 
 
 
 
Figure 4.2: Knowledge Discovery in databases (KDD)process (Kavakiotis et al., 
2017, 106) 
The monitoring of blood glucose can be significantly improved by integrating 
artificial pancreas to machine learning mechanism. As shown above, Dassau et al. 
integrated the artificial pancreas with cloud computing in order to change patients’ basal 
insulin delivery settings on a weekly basis without the intervention of clinician. Figure 
4.2 above shows the knowledge discovery in databases (KDD) process; the process 
explains how data obtained from a patient is ultimately converted into knowledge. Out of 
the 5 steps outlined above, the most important step is the data mining because it is the 
step where the machine learning algorithm analyses the data; it processes the data and 
turn it into discernible pattern (Kavakiotis et al., 2017, p. 106). If the credibility of the 
developed machine learning algorithm is high, then this mechanism can be helpful to 
patient as they will not have to constantly monitor their blood glucose level. 
As shown in chapter 2 section 2.3, each percentage of HbA1c corresponds to 
different mean glucose level and in this project, and the diagnostic diabetes range was 
used for monitoring purposes because each patient hyperglycemic range varies; thus, 
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machine learning algorithm such as artificial neural network can be combined with the 
fuzzy logic system to adjust patient’s blood glucose level range without physician’s 
consultation.   
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CHAPTER 5: CONCLUSION 
 
 Fuzzy logic system developed in this project is shown to be able to monitor the 
blood glucose level of a patient by indicating the condition of the patient at certain level. 
The result shows that the system predicted condition is almost similar to the real 
condition, with the percent accuracy of 83%. The complication of this project occurred 
when it was found that every patient will have different hyperglycemic level and thus the 
blood glucose range for diagnostic purposes was used; nevertheless, the blood glucose 
range in the system can be easily change without deep understanding of abstract 
mathematics. Another complication occurred in the project is patient’s metabolism rate; 
physical activities affect the metabolism rate of a patient and thus affect the second input 
of the system, which is time after meal. The solution for this problem is to add a third 
input variable with the help of expert. Furthermore, the emerging of machine learning 
will help in adjusting the blood glucose range without physician’s input. In the future, the 
fuzzy logic system developed in this project can be combined with machine learning 
algorithm such as neural network system to improve patient’s blood glucose level.  
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